Novo Nordisk A/S (NVO)
46.94
+0.20
(+0.44%)
USD |
NYSE |
Aug 24, 16:00
47.05
+0.10
(+0.22%)
After-Hours: 20:00
Novo Nordisk 1 Year Total Returns (Daily) : -11.68% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | -11.68% |
| August 20, 2026 | -10.96% |
| August 19, 2026 | -11.09% |
| August 18, 2026 | -10.89% |
| August 17, 2026 | -9.30% |
| August 14, 2026 | -5.81% |
| August 13, 2026 | -4.01% |
| August 12, 2026 | -2.55% |
| August 11, 2026 | -1.09% |
| August 10, 2026 | -2.28% |
| August 07, 2026 | 1.36% |
| August 06, 2026 | 5.93% |
| August 05, 2026 | -1.38% |
| August 04, 2026 | -5.13% |
| August 03, 2026 | 2.19% |
| July 31, 2026 | 4.60% |
| July 30, 2026 | 7.88% |
| July 29, 2026 | -0.00% |
| July 28, 2026 | -22.77% |
| July 27, 2026 | -27.56% |
| July 24, 2026 | -27.89% |
| July 23, 2026 | -28.05% |
| July 22, 2026 | -24.54% |
| July 21, 2026 | -20.46% |
| July 20, 2026 | -19.33% |
| Date | Value |
|---|---|
| July 17, 2026 | -19.40% |
| July 16, 2026 | -19.70% |
| July 15, 2026 | -21.34% |
| July 14, 2026 | -25.57% |
| July 13, 2026 | -25.24% |
| July 10, 2026 | -27.13% |
| July 09, 2026 | -26.65% |
| July 08, 2026 | -26.58% |
| July 07, 2026 | -25.11% |
| July 06, 2026 | -25.53% |
| July 02, 2026 | -24.47% |
| July 01, 2026 | -26.95% |
| June 30, 2026 | -27.36% |
| June 29, 2026 | -26.21% |
| June 26, 2026 | -25.75% |
| June 25, 2026 | -26.03% |
| June 24, 2026 | -29.90% |
| June 23, 2026 | -28.87% |
| June 22, 2026 | -34.96% |
| June 18, 2026 | -38.97% |
| June 17, 2026 | -38.78% |
| June 16, 2026 | -40.87% |
| June 15, 2026 | -42.47% |
| June 12, 2026 | -43.38% |
| June 11, 2026 | -41.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 4.92% |
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| Novartis AG | 29.08% |